Home RuiLishi Hair Restoration Reimagines Industry Standards with Client-Centric Approach and Launches 'Ten-Zone Precision Pricing Model'

RuiLishi Hair Restoration Reimagines Industry Standards with Client-Centric Approach and Launches 'Ten-Zone Precision Pricing Model'

Sep 14, 2019 12:59 CST Updated 12:59

Xi’an, China, September 12, 2019 – Ruilishi Hair Transplantation held a press conference titled “Launch of the ‘Ten-Point Density’ Hair Loss Area-Based Pricing Standard and the Global Debut of the Ruilishi Examination-Diagnosis-Treatment-Maintenance System for Hair Loss.” Themed “Medical Benevolence, Technology for All,” the event started from the essence of medical care and centered on customer interests. It exposed multiple hidden practices and lack of transparency in consumer pricing within the hair transplantation industry, directly targeting the chaotic consumption patterns behind the industry’s apparent prosperity. The initiative aims to promote the establishment of a “scientific, transparent, and people-benefiting” order for hair transplantation treatment, foster healthy industry development, and create a more scientific, safe, and effective hair transplantation environment for individuals suffering from hair loss.


1.png

    

Attendees included management personnel at all levels of Ruilishi Hair Transplantation, along with nearly 700 medical and marketing staff from across China. Professor Andy Goren, Global Medical Director of Ruilishi, who is currently establishing a new dermatology research laboratory in Israel, sent a special congratulatory video message. Authoritative industry experts from organizations such as the American Hair Loss Association, AB Bio (USA), and the Korean Hair Association highly affirmed the theme and content of this launch event. They unanimously stated that the billing standard for “Shi Quan Shi Mi” hair loss areas represents a significant innovation in the hair loss industry, and predicted that this more scientific and transparent billing standard will become increasingly widespread in the near future.


2.png


Ms. Zhao Xiaoxia, CEO of Ruilishi Hair Transplantation, as the keynote speaker at the press conference, explicitly stated that “the essence of healthcare is benevolence; only healthcare enterprises committed to benevolence can achieve long-term success, as this aligns with the rights and interests of consumers. The essence of technology is inclusiveness; only by providing high-quality, more affordable technologies and services to a broader consumer base can we ultimately earn consumers’ long-term trust.” As the first hair transplantation brand in the industry to explicitly advocate “Benevolent Healthcare, Inclusive Technology,” Ruilishi possesses both the capability and the resolve to break the long-standing opacity in consumption within the hair transplantation industry, return benefits to customers, and enable more individuals to access high-quality hair transplantation services. This ensures that patients no longer entrust their non-renewable hair follicle resources to unscrupulous institutions offering low prices and substandard quality due to financial constraints.

 

Ms. Zhao Xiaoxia stated that while any innovation inevitably impacts the interests of some stakeholders, she and Ruilishi firmly adhere to the business principle of “Healthcare for Good, Inclusive Technology.” They are committed to viewing the relationship between medical institutions and patients from a more long-term and altruistic perspective, and are willing to make their due contributions to the long-term, sustainable, and healthy development of the hair transplantation industry, as well as to the sustained growth of Ruilishi.


3.png


For consumers, there is a lag period before the results of hair transplantation become apparent. This delay provides a shield for many unscrupulous institutions, emboldening them to disregard medical principles. They engage in practices such as making exaggerated promises before surgery, maliciously inflating prices during the procedure, and reneging on their responsibilities afterward. As a result, batch after batch of hair loss patients undergo hair transplantation in confusion. Although they subsequently employ various means to defend their rights, the lack of transparency within the industry makes it difficult for them to truly protect their interests.

 

Ms. Zhao Xiaoxia patiently explained the original intention behind Ruilishi’s introduction of the “Comprehensive Density-Based Zonal Pricing Standard for Hair Loss”: “Ruilishi has been dedicated to the hair transplantation industry for 22 years. Since our inception, our corporate DNA has dictated that we cannot engage in arbitrary boasting or make excessive promises that contradict the fundamental principles of medicine. Particularly in the past two years, the hair transplantation industry has experienced explosive growth. The entire sector has witnessed unprecedented exaggeration and short-sighted pursuit of quick profits, whether from peer brands rapidly expanding their footprint or from lesser-known institutions that entered the market with great fanfare only to disappear quietly after seeking rapid financial gains. As a participant in this industry, Ruilishi cannot remain isolated from these trends. We have continuously reflected on how to act in a manner that aligns with customer interests, market trends, and corporate development requirements. To this end, we engaged in extensive communications with numerous professionals worldwide, ultimately giving rise to the ‘Comprehensive Density-Based Zonal Pricing Standard for Hair Loss’ that we see today. Ruilishi hopes to influence and benefit more people. This is driven by our corporate DNA of ‘goodness and scientific innovation,’ as well as our ultimate mission to achieve ‘a world without hair loss.’”


4.png


How Exactly Does the “Shi Quan Shi Mi” Hair Loss Zone-Based Pricing Model Realize Ruilishi’s Claim of “Disrupting and Reshaping Industry Rules”?We have learned that the “Shi Quan Shi Mi” hair loss zone-based pricing standard is built on modeling and calculations derived from data on hundreds of thousands of individuals with hair loss. It divides hair loss areas into “9+1” distinct zones, with charges based on these zones. The number of units per zone is determined by the client’s desired density and donor area conditions, with no upper limit, aiming for optimal results. Moreover, the more zones a client requires, the lower the unit price per zone becomes. This achieves a cost structure of “capped prices with unlimited quantity,” perfectly aligning with the essence of hair transplantation: redistributing hair to achieve completeness and aesthetic appeal. Under the “Shi Quan Shi Mi” pricing standard, clients enjoy full transparency and informed consent, eliminating concerns about mid-procedure price hikes or the awkward situation of having to pay more for better results. Most importantly, a procedure that originally cost around RMB 30,000 has been directly reduced to RMB 20,000. Compared to other hair transplant institutions of similar quality in the market, this price remains more than 40% lower even after their discounts. This can rightly be described as an unprecedented move toward inclusive affordability.“Scientific, transparent, and inclusive—this is our original intention,” revealed Mr. Chen from Ruilishi’s Integrated Marketing Center. “We recognize that this approach entails significant costs, but we are committed and determined to reshape our relationship with clients and redefine their understanding of hair transplantation. Our goal is to help more people address hair loss issues. We believe that benefiting our clients is the right thing to do, and we are willing to do what is right.”

 

As a well-established chain brand specializing in hair transplantation within the medical industry, Ruilishi Hair Transplantation maintains a notably “low-profile” advertising presence, relying primarily on its brand equity and customer relationship management cultivated over years of dedicated operation. However, Ruilishi’s R&D expenditure ranks first in the industry. As a small-to-medium-sized private medical enterprise, Ruilishi has invested tens of millions of RMB in research and development over the past five years alone. Through collaborations with domestic and international professional R&D institutions as well as independent research efforts, Ruilishi currently holds exclusive Chinese rights to multiple global patents and possesses globally innovative patents for numerous technologies. Centered on its mission of “A World Without Hair Loss,” the company is committed to building a unique and comprehensive hair health industry chain.


5.png


Ruili Shi Hair Transplantation Center issues a solemn reminder to all individuals experiencing hair loss: There is a 9-12 month latency period before the final results of hair transplantation become apparent. Before proceeding with the procedure, it is essential to engage in thorough communication with your physician and develop a treatment plan aligned with your desired outcomes. Exercise caution to avoid preoperative overpromising, low-price baiting, and malicious price increases during the surgery. Safeguard your rights and interests proactively before making any decisions. We wish every individual troubled by hair loss an early "liberation" from this concern.